Click Arrow to Listen
You can also download a PHONE APP to listen without interruption:
Subscribe to Dark To Light With Frank & Beanz on Apple Podcasts, Stitcher, TuneIn Radio, Google Play, the iHeartRadio app, and now on Spotify!
We are honored to be joined today by Dr. Peter McCullough, one of the pioneers in treating COVID-19, developing an early treatment protocol for the virus which has been hugely successful at preventing hospitalization and death. Make sure to listen to every last second of this amazing interview.
Dr. Peter McCullough is an internist, cardiologist, epidemiologist, and Professor of Medicine, Texas Christian University and the University of North Texas Health Sciences Center School of Medicine.
He maintains ABIM certification in internal medicine and cardiovascular diseases. He practices internal medicine including the management of common infectious diseases as well as the cardiovascular complications of both the viral infection and the injuries developing after the COVID-19 vaccine in Dallas TX, USA. Since the outset of the pandemic, Dr. McCullough has been a leader in the medical response to the COVID-19 disaster and has published “Pathophysiological Basis and Rationale for Early Outpatient Treatment of SARS-CoV-2 (COVID-19) Infection” the first synthesis of sequenced multidrug treatment of ambulatory patients infected with SARS-CoV-2 in the American Journal of Medicine and subsequently updated in Reviews in Cardiovascular Medicine. He has 46 peer-reviewed publications on the infection and has commented extensively on the medical response to the COVID-19 crisis in The Hill and on FOX NEWS Channel.
On November 19, 2020, Dr. McCullough testified in the US Senate Committee on Homeland Security and Governmental Affairs and throughout 2021 in the Texas Senate Committee on Health and Human Services, Colorado General Assembly, and New Hampshire Senate concerning many aspects of the pandemic response.
Dr. McCullough has had one full year of dedicated academic and clinical efforts in combating the SARS-CoV-2 virus and in doing so, has reviewed thousands of reports, participated in scientific congresses, group discussions, press releases, and has been considered among the world’s experts on COVID-19.
LINKS WE DISCUSSED
